In the mouse model, it was observed that hepatocyte-specific depletion of ANGPTL4 prevents diet-induced obesity, leads to a decrease in circulating triglycerides, increases insulin sensitivity and glucose tolerance and inhibits the progression of atherosclerosis [18]. This evidence concerns the gene ANGPTL4 and atherosclerosis.